Charles Swanton
Affiliations: | The Francis Crick Institute, London, England, United Kingdom |
Google:
"Charles Swanton"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lu WT, Zalmas LP, Bailey C, et al. (2024) TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling. Nature Cell Biology |
| Zucker M, Perry MA, Gould SI, et al. (2024) Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer. Cell |
| Lucas O, Ward S, Zaidi R, et al. (2024) Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER. Nature Genetics |
| Giangreco G, Rullan A, Naito Y, et al. (2024) Cancer cell - Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma. Iscience. 27: 110635 |
| Dietzen M, Zhai H, Lucas O, et al. (2024) Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution. Nature Communications. 15: 6039 |
| Hobor S, Al Bakir M, Hiley CT, et al. (2024) Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nature Communications. 15: 4871 |
| Hill W, Weeden CE, Swanton C. (2024) Tumor Promoters and Opportunities for Molecular Cancer Prevention. Cancer Discovery. OF1-OF7 |
| Passaro A, Al Bakir M, Hamilton EG, et al. (2024) Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell. 187: 1617-1635 |
| Swanton C, Bernard E, Abbosh C, et al. (2024) Embracing cancer complexity: Hallmarks of systemic disease. Cell. 187: 1589-1616 |
| Usaite I, Biswas D, Dijkstra K, et al. (2023) Quantifying the impact of immunotherapy on RNA dynamics in cancer. Journal For Immunotherapy of Cancer. 11 |